Iridex (IRIX) Current Deferred Tax Assets (2015)
Iridex's (IRIX) quarterly Current Deferred Tax Assets came in at $1.6 million in Q4 2015, little changed quarter-over-quarter from $1.6 million in Q3 2015.
Iridex (IRIX) Current Deferred Tax Assets (2015) Analysis & Trends
Iridex's Current Deferred Tax Assets history runs 1 years deep, the most recent figure standing at $1.6 million for Q4 2015.
- On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $1.6 million in Q4 2015; TTM through Oct 2015 was $1.6 million, a N/A change from a year earlier, with the FY2015 full-year figure at $1.6 million, changed N/A from the prior year.
- Current Deferred Tax Assets steadied at $1.6 million in Q4 2015 per IRIX's latest filing, from $1.6 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $1.6 million in Q1 2015 and bottomed at $1.6 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 3, 2015 | 1.63 Mn |
| Oct 3, 2015 | 1.63 Mn |
| Jul 4, 2015 | 1.63 Mn |
| Jul 4, 2015 | 1.63 Mn |
| Apr 4, 2015 | 1.63 Mn |
| Apr 4, 2015 | 1.63 Mn |
| Jan 3, 2015 | 1.63 Mn |
| Jan 3, 2015 | 1.63 Mn |